News
Search results
Showing matches with:
Researchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues
19 01 2026
A multidisciplinary team co-led by the UAB has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholesterol and other essential lipids directly from the human body through the P116 protein. The discovery, published in Nature Communications, opens the door to using a modified version of this microorganism as a biotechnological platform to study and treat liver and atherosclerotic diseases.
In Memoriam: Professor Uwe Mamat
13 01 2026
It is with profound sadness that we announce the passing of Professor Uwe Mamat, a distinguished and deeply cherished researcher in the field of applied microbiology. Professor Mamat was admired not only for his scientific acumen and substantial contributions to microbiological research but also for his warmth, empathy, generosity, and unwavering dedication, to his work, his collaborators, and his wife Claudia.
An IBB project, recognized in the 2025 Call for Health Research of the "la Caixa" Foundation
20 11 2025
The researcher Salvador Ventura will lead the IBB research project that has obtained funding in the VIII Call for Health Research of the ”la Caixa” Foundation. The project proposes an innovative approach that could improve the treatment of Parkinson's disease.
The researcher Rosanna Rossi presents advances in the early diagnosis of Alzheimer¿s disease
29 10 2025
The SENS4AD project focuses on developing a biosensor for the early diagnosis of Alzheimer’s disease and the stratification of patient risk.
New advances in promoter regulation for protein production in yeast
21 10 2025
The Yeast Molecular Biology Group at IBB publishes two key research papers on the use of alkaline pH-activated promoters in Saccharomyces cerevisiae and Komagataella phaffii, with relevant industrial applications
Protein nanorings designed to detect and neutralise SARS-CoV2 virus
16 10 2025
An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and neutralising the SARS-CoV2 virus. The study, published in Advanced HealthCare Materials, highlights the versatility of the system devised to design the nanorings, which can integrate therapeutic and diagnostic capabilities, and be adapted to combat other viruses.
2025 Ranking of the Top 2% of Scientists with the Most Impact in the World
01 10 2025
Joan Cerdà, Xavier Daura, Salvador Ventura and Antonio Villaverde, highlighted for the impact of their research
Nit de la Recerca 2026 (Research Night)
29 09 2025
IBB researchers have participated in conferences, workshops and guided tours.
Developing a ready-to-use cell therapy to fight cancer more effectively
23 09 2025
Project led by Aura Muntasell, funded by Caixa Impulse call
Esther Vázquez and Antonio Villaverde visit the Ruder Boškovic Research Institute, in Croatia
10 09 2025
Accompanied by representatives of the Delegation of the Government of the Generalitat of Catalonia to the countries of Southeastern Europe